North Carolina 2025-2026 Regular Session

North Carolina House Bill H330 Compare Versions

OldNewDifferences
11 GENERAL ASSEMBLY OF NORTH CAROLINA
22 SESSION 2025
3-H 2
3+H 1
44 HOUSE BILL 330
5-Committee Substitute Favorable 3/18/25
5+
66
77 Short Title: Controlled Substances Act - Updates. (Public)
8-Sponsors:
9-Referred to:
8+Sponsors: Representatives Huneycutt, Miller, Pyrtle, and Rhyne (Primary Sponsors).
9+For a complete list of sponsors, refer to the North Carolina General Assembly web site.
10+Referred to: Judiciary 2, if favorable, Rules, Calendar, and Operations of the House
1011 March 10, 2025
11-*H330 -v-2*
12+*H330 -v-1*
1213 A BILL TO BE ENTITLED 1
1314 AN ACT TO UPDATE THE CONTROLLED SUBSTANC ES ACT. 2
1415 The General Assembly of North Carolina enacts: 3
1516 SECTION 1.(a) G.S. 90-89(1) reads as rewritten: 4
1617 "(1) Opiates. – Any of the following opiates or opioids, including the isomers, 5
1718 esters, ethers, salts and salts of isomers, esters, and ethers, unless specifically 6
1819 excepted, or listed in another schedule, whenever the existence of such 7
1920 isomers, esters, ethers, and salts is possible within the specific chemical 8
2021 designation: 9
2122 … 10
2223 sss. AP-237. 11
2324 ttt. 2-methyl AP-237. 12
2425 uuu. (ortho, meta, or para)-methyl AP-237. 13
2526 vvv. AP-238. 14
2627 www. (ortho, meta, or para)-hydroxy 2-methyl AP-237. 15
2728 xxx. 2-Naphthyl U-47700. 16
2829 yyy. 1-Naphthyl U-47700. 17
2930 zzz. 4-(Trifluoromethyl) U-47700. 18
3031 aaaa. Methoxy U-47700. 19
3132 bbbb. Furanyl UF-17. 20
3233 cccc. Cyclopropyl U-47700. 21
3334 dddd. Phenyl U-47700. 22
3435 eeee. Ethyl U-47700. 23
3536 ffff. (2,3- or 3,4)-difluoro-N,N-didesmethyl U-47700. 24
3637 gggg. (2,3- or 3,4)-difluoro U-49900. 25
3738 hhhh. (2,3- or 3,4)-difluoro-N-desmethyl U-47700. 26
3839 iiii. 4-fluoro U-47931E. 27
3940 jjjj. (2,3- or 3,4)-difluoro U-51754. 28
4041 kkkk. (2,3- or 3,4)-difluoro Isopropyl U-47700. 29
4142 llll. (2,3- or 3,4)-difluoro Propyl U-47700. 30
4243 mmmm. (2,3- or 3,4)-difluoro U-50488. 31
4344 nnnn. (2,3- or 3,4)-difluoro U-48800. 32
4445 oooo. (2,3- or 3,4 or 2,4)-difluoro U-47700. 33
4546 pppp. UF-17. 34
46-qqqq. U-47109. 35
47-rrrr. U-48520. 36 General Assembly Of North Carolina Session 2025
48-Page 2 House Bill 330-Second Edition
49-ssss. N,N-didesmethyl U-47700. 1
50-tttt. U-62066. 2
51-uuuu. Propyl U-47700. 3
52-vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754. 4
53-wwww. 4-phenyl U-51754. 5
54-xxxx. N-desmethyl U-47700. 6
55-yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700. 7
56-zzzz. N-methyl U-47931E. 8
57-aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700. 9
58-bbbbb. U-69593. 10
59-ccccc. U-50488. 11
60-ddddd. U-48753E. 12
61-eeeee. U-47931E." 13
62-SECTION 1.(b) G.S. 90-89(1a) reads as rewritten: 14
63-"(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another 15
64-schedule, or contained within a pharmaceutical product approved by the 16
65-United States Food and Drug Administration, any compound structurally 17
66-derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide 18
67-(Fentanyl) by any substitution on or replacement of the phenethyl group, any 19
68-substitution on the piperidine ring, any substitution on or replacement of the 20
69-propanamide group, any substitution on the anilido phenyl group, or any 21
70-combination of the above unless specifically excepted or listed in another 22
71-schedule to include their salts, isomers, and salts of isomers. Fentanyl 23
72-derivatives include, but are not limited to, the following: 24
47+qqqq. U-47109. 35 General Assembly Of North Carolina Session 2025
48+Page 2 House Bill 330-First Edition
49+rrrr. U-48520. 1
50+ssss. N,N-didesmethyl U-47700. 2
51+tttt. U-62066. 3
52+uuuu. Propyl U-47700. 4
53+vvvv. (2,3- or 3,4)-Ethylenedioxy U-51754. 5
54+wwww. 4-phenyl U-51754. 6
55+xxxx. N-desmethyl U-47700. 7
56+yyyy. (2,3- or 3,4)-Ethylenedioxy U-47700. 8
57+zzzz. N-methyl U-47931E. 9
58+aaaaa. (2,3- or 3,4)-Methylenedioxy U-47700. 10
59+bbbbb. U-69593. 11
60+ccccc. U-50488. 12
61+ddddd. U-48753E. 13
62+eeeee. U-47931E." 14
63+SECTION 1.(b) G.S. 90-89(1a) reads as rewritten: 15
64+"(1a) Fentanyl derivatives. – Unless specifically excepted, listed in another 16
65+schedule, or contained within a pharmaceutical product approved by the 17
66+United States Food and Drug Administration, any compound structurally 18
67+derived from N-[1-(2-phenylethyl)-4-piperidinyl]-N-phenylpropanamide 19
68+(Fentanyl) by any substitution on or replacement of the phenethyl group, any 20
69+substitution on the piperidine ring, any substitution on or replacement of the 21
70+propanamide group, any substitution on the anilido phenyl group, or any 22
71+combination of the above unless specifically excepted or listed in another 23
72+schedule to include their salts, isomers, and salts of isomers. Fentanyl 24
73+derivatives include, but are not limited to, the following: 25
74+… 26
75+f.27
76+ N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana28
77+mide (also known as 2-fluorofentanyl).(also known as 29
78+ortho-fluorofentanyl). 30
79+g.31
80+ N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana32
81+mide (also known as 3-fluorofentanyl).(also known as 33
82+meta-fluorofentanyl). 34
83+… 35
84+i.36
85+ N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]37
86+-propanamide (also known as 4-fluoroisobutyryl fentanyl, 38
87+4-FIBF).(also known as 4-fluoroisobutyryl fentanyl). 39
88+j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide 40
89+(also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as 41
90+4-fluorobutyryl fentanyl)." 42
91+SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read: 43
92+"(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class, 44
93+including any of the following derivatives, their salts, isomers, or salts of 45
94+isomers unless specifically utilized as part of the manufacturing process by a 46
95+commercial industry of a substance or material not intended for human 47
96+ingestion or consumption, as a prescription administered under medical 48
97+supervision, or for research at a recognized institution, whenever the existence 49
98+of these salts, isomers, or salts of isomers is possible within the specific 50
99+chemical designation or unless specifically excepted or listed in this or another 51 General Assembly Of North Carolina Session 2025
100+House Bill 330-First Edition Page 3
101+schedule, structurally derived from benzimidazole by substitution at the 1
102+1-position nitrogen with an ethylamine group, and by substitution at the 2
103+2-position carbon with a benzyl group, whether or not the compound is further 3
104+modified in any of the following ways: 4
105+a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the 5
106+1-position ethylamine group, or by inclusion of the nitrogen in a cyclic 6
107+structure. 7
108+b. By substitution on the 2'-methylene carbon of the benzyl group by 8
109+alkyl or carboxamide groups. 9
110+c. By replacement of the 2'-methylene carbon group with an ethylbenzyl, 10
111+thiophenol, or methoxybenzene group, which may be further 11
112+substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide 12
113+groups. 13
114+d. By substitution at the 2'-position, 3'-position, or 4'-position of the 14
115+benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide, 15
116+or sulfide groups. 16
117+e. By replacement of a phenyl hydrogen atom at either the 5-position or 17
118+6-position of the benzimidazole core with a nitro, or primary amine 18
119+group." 19
120+SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten: 20
121+"mm. 5-methoxy-N-methyl-N-propyltryptamine 21
122+(5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine 22
123+(5-MeO-MiPT)." 23
124+SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read: 24
125+"j. Bromazolam." 25
126+SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten: 26
127+"j. Substituted cathinones. A compound, other than bupropion, that is 27
128+structurally derived from 2-amino-1-phenyl-1-propanone by 28
129+modification in any of the following ways: (i) by substitution in the 29
130+phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, 30
131+or halide substituents, whether or not further substituted in the phenyl 31
132+ring by one or more other univalent substituents; (ii) by substitution at 32
133+the 3-position to any extent; or (iii) by substitution at the nitrogen atom 33
134+with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by 34
135+inclusion of the nitrogen atom in a cyclic structure. For the purpose of 35
136+this paragraph, the term "isomer" includes the optical, positional, or 36
137+geometric isomer." 37
138+SECTION 1.(g) G.S. 90-89(7) reads as rewritten: 38
139+"(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound 39
140+that (i) is a cannabinoid receptor agonist and mimics the pharmacological 40
141+effect of naturally occurring substances or (ii) has a stimulant, depressant, or 41
142+hallucinogenic effect on the central nervous system that is not listed as a 42
143+controlled substance in Schedules I through V, and is not an FDA-approved 43
144+drug. Synthetic cannabinoids include, but are not limited to, the substances 44
145+listed in sub-subdivisions a. through p. v. of this subdivision and any substance 45
146+that contains any quantity of their salts, isomers (whether optical, positional, 46
147+or geometric), homologues, and salts of isomers and homologues, unless 47
148+specifically excepted, whenever the existence of these salts, isomers, 48
149+homologues, and salts of isomers and homologues is possible within the 49
150+specific chemical designation. The following substances are examples of 50 General Assembly Of North Carolina Session 2025
151+Page 4 House Bill 330-First Edition
152+synthetic cannabinoids and are not intended to be inclusive of the substances 1
153+included in this Schedule: 2
154+… 3
155+l. Indole carboxamides. Any compound structurally derived from 4
156+1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in 5
157+one or both of the following ways: 6
158+1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 7
159+cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 8
160+1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 9
161+1-(N-methyl-2-pyrrolidinyl)methyl, 10
162+1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 11
163+benzyl, or halo benzyl group; andor 12
164+2. At the nitrogen of the carboxamide by a phenyl, benzyl, 13
165+naphthyl, adamantyl, cyclopropyl, or propionaldehyde 14
166+group;group, or methyl 3,3-dimethyl-butanoate group; 15
167+whether or not the compound is further modified to any extent 16
168+in the following ways: (i) substitution to the indole ring to any 17
169+extent, (ii) substitution to the phenyl, benzyl, naphthyl, 18
170+adamantyl, cyclopropyl, or propionaldehyde group to any 19
171+extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 20
172+(iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 21
173+naphthyl, adamantyl, or cyclopropyl ring. Substances in this 22
174+class include, but are not limited to: SDB-001 and 23
175+STS-135.STS-135 and MDMB-ICA. 24
73176 … 25
74-f.26
75- N-(2-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana27
76-mide (also known as 2-fluorofentanyl).(also known as 28
77-ortho-fluorofentanyl). 29
78-g.30
79- N-(3-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-propana31
80-mide (also known as 3-fluorofentanyl).(also known as 32
81-meta-fluorofentanyl). 33
82-… 34
83-i.35
84- N-(4-fluorophenyl)-2-methyl-N-[1-(2-phenylethyl)-4-piperidinyl]36
85--propanamide (also known as 4-fluoroisobutyryl fentanyl, 37
86-4-FIBF).(also known as 4-fluoroisobutyryl fentanyl). 38
87-j. N-(4-fluorophenyl)-N-[1-(2-phenylethyl)-4-piperidinyl]-butanamide 39
88-(also known as 4-fluorobutyryl fentanyl, 4-FBF).(also known as 40
89-para-fluorobutyryl fentanyl)." 41
90-SECTION 1.(c) G.S. 90-89 is amended by adding a new subdivision to read: 42
91-"(1b) Nitazene derivatives. – The N-substituted benzimidazole structural class, 43
92-including any of the following derivatives, their salts, isomers, or salts of 44
93-isomers unless specifically utilized as part of the manufacturing process by a 45
94-commercial industry of a substance or material not intended for human 46
95-ingestion or consumption, as a prescription administered under medical 47
96-supervision, or for research at a recognized institution, whenever the existence 48
97-of these salts, isomers, or salts of isomers is possible within the specific 49
98-chemical designation or unless specifically excepted or listed in this or another 50
99-schedule, structurally derived from benzimidazole by substitution at the 51 General Assembly Of North Carolina Session 2025
100-House Bill 330-Second Edition Page 3
101-1-position nitrogen with an ethylamine group, and by substitution at the 1
102-2-position carbon with a benzyl group, whether or not the compound is further 2
103-modified in any of the following ways: 3
104-a. By monoalkyl or dialkyl substitution on the 1'-nitrogen of the 4
105-1-position ethylamine group, or by inclusion of the nitrogen in a cyclic 5
106-structure. 6
107-b. By substitution on the 2'-methylene carbon of the benzyl group by 7
108-alkyl or carboxamide groups. 8
109-c. By replacement of the 2'-methylene carbon group with an ethylbenzyl, 9
110-thiophenol, or methoxybenzene group, which may be further 10
111-substituted with alkyl, hydroxyl, alkoxy, acetoxy, halide, or sulfide 11
112-groups. 12
113-d. By substitution at the 2'-position, 3'-position, or 4'-position of the 13
114-benzyl group, or both, with alkyl, hydroxyl, alkoxy, acetoxy, halide, 14
115-or sulfide groups. 15
116-e. By replacement of a phenyl hydrogen atom at either the 5-position or 16
117-6-position of the benzimidazole core with a nitro, or primary amine 17
118-group." 18
119-SECTION 1.(d) G.S. 90-89(3)mm. reads as rewritten: 19
120-"mm. 5-methoxy-N-methyl-N-propyltryptamine 20
121-(5-MeO-MiPT).5-methoxy-N-methyl-N-isopropyltryptamine 21
122-(5-MeO-MiPT)." 22
123-SECTION 1.(e) G.S. 90-89(4) is amended by adding a new sub-subdivision to read: 23
124-"j. Bromazolam." 24
125-SECTION 1.(f) G.S. 90-89(5)j. reads as rewritten: 25
126-"j. Substituted cathinones. A compound, other than bupropion, that is 26
127-structurally derived from 2-amino-1-phenyl-1-propanone by 27
128-modification in any of the following ways: (i) by substitution in the 28
129-phenyl ring to any extent with alkyl, alkoxy, alkylenedioxy, haloalkyl, 29
130-or halide substituents, whether or not further substituted in the phenyl 30
131-ring by one or more other univalent substituents; (ii) by substitution at 31
132-the 3-position to any extent; or (iii) by substitution at the nitrogen atom 32
133-with alkyl, dialkyl, benzyl, cycloalkyl, or methoxybenzyl groups or by 33
134-inclusion of the nitrogen atom in a cyclic structure. For the purpose of 34
135-this paragraph, the term "isomer" includes the optical, positional, or 35
136-geometric isomer." 36
137-SECTION 1.(g) G.S. 90-89(7) reads as rewritten: 37
138-"(7) Synthetic cannabinoids. – Any quantity of any synthetic chemical compound 38
139-that (i) is a cannabinoid receptor agonist and mimics the pharmacological 39
140-effect of naturally occurring substances or (ii) has a stimulant, depressant, or 40
141-hallucinogenic effect on the central nervous system that is not listed as a 41
142-controlled substance in Schedules I through V, and is not an FDA-approved 42
143-drug. Synthetic cannabinoids include, but are not limited to, the substances 43
144-listed in sub-subdivisions a. through p. v. of this subdivision and any substance 44
145-that contains any quantity of their salts, isomers (whether optical, positional, 45
146-or geometric), homologues, and salts of isomers and homologues, unless 46
147-specifically excepted, whenever the existence of these salts, isomers, 47
148-homologues, and salts of isomers and homologues is possible within the 48
149-specific chemical designation. The following substances are examples of 49
150-synthetic cannabinoids and are not intended to be inclusive of the substances 50
151-included in this Schedule: 51 General Assembly Of North Carolina Session 2025
152-Page 4 House Bill 330-Second Edition
153-… 1
154-l. Indole carboxamides. Any compound structurally derived from 2
155-1H-indole-3-carboxamide or 1H-indole-2-carboxamide substituted in 3
156-one or both of the following ways: 4
157-1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 5
158-cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 6
159-1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 7
160-1-(N-methyl-2-pyrrolidinyl)methyl, 8
161-1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 9
162-benzyl, or halo benzyl group; andor 10
163-2. At the nitrogen of the carboxamide by a phenyl, benzyl, 11
164-naphthyl, adamantyl, cyclopropyl, or propionaldehyde 12
165-group;group, or methyl 3,3-dimethyl-butanoate group; 13
166-whether or not the compound is further modified to any extent 14
167-in the following ways: (i) substitution to the indole ring to any 15
168-extent, (ii) substitution to the phenyl, benzyl, naphthyl, 16
169-adamantyl, cyclopropyl, or propionaldehyde group to any 17
170-extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 18
171-(iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 19
172-naphthyl, adamantyl, or cyclopropyl ring. Substances in this 20
173-class include, but are not limited to: SDB-001 and 21
174-STS-135.STS-135 and MDMB-ICA. 22
175-… 23
176-n. Indazole carboxaldehydes. Any compound structurally derived from 24
177-1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde 25
178-substituted in both of the following ways: 26
179-… 27
180-2. At the carbon of the carboxaldehyde by a phenyl, benzyl, 28
181-naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 29
182-whether or not the compound is further modified to any extent 30
183-in the following ways: (i) substitution to the indazole ring to 31
184-any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 32
185-adamantyl, cyclopropyl, or propionaldehyde group to any 33
186-extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 34
187-or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 35
188-naphthyl, adamantyl, or cyclopropyl ring. 36
189-o. Indazole carboxamides. Any compound structurally derived from 37
190-1H-indazole-3-carboxamide or 1H -indazole-2-carboxamide 38
191-substituted in one or both of the following ways: 39
192-1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 40
193-cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 41
194-1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 42
195-1-(N-methyl-2-pyrrolidinyl)methyl, 43
196-1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 44
197-benzyl, or halo benzyl group; andor 45
198-2. At the nitrogen of the carboxamide by a phenyl, benzyl, 46
199-naphthyl, adamantyl, cyclopropyl, or propionaldehyde 47
200-group;group, or methyl 3,3-dimethyl-butanoate group; 48
201-whether or not the compound is further modified to any extent in the 49
202-following ways: (i) substitution to the indazole ring to any extent, (ii) 50
203-substitution to the phenyl, benzyl, naphthyl, adamantyl, cyclopropyl, 51 General Assembly Of North Carolina Session 2025
204-House Bill 330-Second Edition Page 5
205-or propionaldehyde group to any extent, (iii) a nitrogen heterocyclic 1
206-analog of the indazole ring, or (iv) a nitrogen heterocyclic analog of 2
207-the phenyl, benzyl, naphthyl, adamantyl, or cyclopropyl ring. 3
208-Substances in this class include, but are not limited to: AKB-48, 4
209-fluoro-AKB-48, APINCACA, AB-PINACA, AB-FUBINACA, 5
210-ADB-FUBINACA, and ADB-PINACA.ADB-PINACA, 6
211-ADB-INACA, MDMB -INACA, MDMB -5Me-INACA, and 7
212-MDMB-5Br-INACA. 8
213-… 9
214-s. Oxindoles. Any compound structurally derived from 10
215-3-hydrazonoindolin-2-one substituted in one or both of the following 11
216-ways: 12
217-1. At the nitrogen atom of the oxoindole ring by an alkyl, 13
218-haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 14
219-cycloalkylethyl; or 15
220-2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl, 16
221-adamantyl, cyclopropyl, or propionaldehyde group; 17
222-whether or not the compound is further modified to any extent 18
223-in the following ways: (i) substitution to the oxoindole ring to 19
224-any extent or (ii) substitution to the phenyl, benzyl, naphthyl, 20
225-adamantyl, cyclopropyl, or propionaldehyde group to any 21
226-extent. Substances in this class include, but are not limited to: 22
227-BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE. 23
228-t. Indole acetamides. Any compound structurally derived from 24
229-1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or 25
230-both of the following ways: 26
231-1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 27
232-cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 28
233-1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 29
234-1-(N-methyl-2-pyrrolidinyl)methyl, 30
235-1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 31
236-benzyl, or halo benzyl group; or 32
237-2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl, 33
238-adamantyl, cyclopropyl, or propionaldehyde group; 34
239-whether or not the compound is further modified to any extent 35
240-in the following ways: (i) substitution to the indole ring to any 36
241-extent, (ii) substitution to the phenyl, benzyl, naphthyl, 37
242-adamantyl, cyclopropyl, or propionaldehyde group to any 38
243-extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 39
244-(iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 40
245-naphthyl, adamantyl, or cyclopropyl ring. Substances in this 41
246-class include, but are not limited to: AFUBIATA, CH-PIATA, 42
247-AB-CHMIATA, ADB-FUBIATA. 43
248-u. Indazole acetaldehydes. Any compound structurally derived from 44
249-1H-indazol-3-ylacetaldehyde or 1H-indazol-2-ylacetaldehyde 45
250-substituted in one or both of the following ways: 46
251-1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 47
252-cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 48
253-1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 49
254-1-(N-methyl-2-pyrrolidinyl)methyl, 50 General Assembly Of North Carolina Session 2025
255-Page 6 House Bill 330-Second Edition
256-1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 1
257-benzyl, or halo benzyl group; or 2
258-2. At the nitrogen of the carboxamide by a phenyl, benzyl, 3
259-naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 4
260-whether or not the compound is further modified to any extent 5
261-in the following ways: (i) substitution to the indazole ring to 6
262-any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 7
263-adamantyl, cyclopropyl, or propionaldehyde group to any 8
264-extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 9
265-or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 10
266-naphthyl, adamantyl, or cyclopropyl ring. Substances in this 11
267-class include, but are not limited to: ADB-BUTINAATA, 12
268-ADB-FUBINAATA. 13
269-v. Pyrazoles. Any compound structurally derived from 1H-pyrazole 14
270-substituted in all of the following ways: 15
271-1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or 16
272-alkenyl group. 17
273-2. At the 3 position of the pyrazole ring by a halo benzyl or 18
274-propionaldehyde group. 19
275-3. At the 5 position of the pyrazole ring by a halo benzyl or 20
276-propionaldehyde group; 21
277-whether or not the compound is further modified by a 22
278-substitution to the propionaldehyde group to any extent. 23
279-Substances in this class include, but are not limited to: 24
280-3,5-ADB-4en-PFUPPYCA, 5-fluoro-3,5-AB-PFUPPYCA." 25
281-SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten: 26
282-"h1. Fentanyl immediate pr ecursor chemical, 27
283-4-anilino-N-phenethyl-4-piperidine 28
284-(ANPP).4-anilino-N-phenethylpiperdine (ANPP)." 29
285-SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten: 30
286-"11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone," 31
287-SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten: 32
288-"16. Mesterolene,Mesterolone," 33
289-SECTION 2. This act is effective when it becomes law. 34
177+n. Indazole carboxaldehydes. Any compound structurally derived from 26
178+1H-indazole-3-carboxaldehyde or 1H-indazole-2-carboxaldehyde 27
179+substituted in both of the following ways: 28
180+… 29
181+2. At the carbon of the carboxaldehyde by a phenyl, benzyl, 30
182+naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 31
183+whether or not the compound is further modified to any extent 32
184+in the following ways: (i) substitution to the indazole ring to 33
185+any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 34
186+adamantyl, cyclopropyl, or propionaldehyde group to any 35
187+extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 36
188+or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 37
189+naphthyl, adamantyl, or cyclopropyl ring. 38
190+o. Indazole carboxamides. Any compound structurally derived from 39
191+1H-indazole-3-carboxamide or 1H -indazole-2-carboxamide 40
192+substituted in one or both of the following ways: 41
193+1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 42
194+cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 43
195+1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 44
196+1-(N-methyl-2-pyrrolidinyl)methyl, 45
197+1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 46
198+benzyl, or halo benzyl group; andor 47
199+2. At the nitrogen of the carboxamide by a phenyl, benzyl, 48
200+naphthyl, adamantyl, cyclopropyl, or propionaldehyde 49
201+group;group, or methyl 3,3-dimethyl-butanoate group; 50 General Assembly Of North Carolina Session 2025
202+House Bill 330-First Edition Page 5
203+whether or not the compound is further modified to any extent 1
204+in the following ways: (i) substitution to the indazole ring to 2
205+any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 3
206+adamantyl, cyclopropyl, or propionaldehyde group to any 4
207+extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 5
208+or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 6
209+naphthyl, adamantyl, or cyclopropyl ring. Substances in this 7
210+class include, but are not limited to: AKB-48, fluoro-AKB-48, 8
211+APINCACA, AB-PINACA, AB -FUBINACA, 9
212+ADB-FUBINACA, and ADB-PINACA.ADB-PINACA, 10
213+ADB-INACA, MDMB-INACA, MDMB-5Me-INACA, and 11
214+MDMB-5Br-INACA. 12
215+… 13
216+s. Oxindoles. Any compound structurally derived from 14
217+3-hydrazonoindolin-2-one substituted in one or both of the following 15
218+ways: 16
219+1. At the nitrogen atom of the oxoindole ring by an alkyl, 17
220+haloalkyl, cyanoalkyl, alkenyl, cycloalkylmethyl, 18
221+cycloalkylethyl; or 19
222+2. At the nitrogen of the hydrazide by a phenyl, benzyl, naphthyl, 20
223+adamantyl, cyclopropyl, or propionaldehyde group; 21
224+whether or not the compound is further modified to any extent 22
225+in the following ways: (i) substitution to the oxoindole ring to 23
226+any extent or (ii) substitution to the phenyl, benzyl, naphthyl, 24
227+adamantyl, cyclopropyl, or propionaldehyde group to any 25
228+extent. Substances in this class include, but are not limited to: 26
229+BZO-POXIZID, BZO-HEXOXIZIDE, 5F-BZO-POXIZIDE. 27
230+t. Indole acetamides. Any compound structurally derived from 28
231+1H-indole-3-acetamide or 1H-indole-2-acetamide substituted in one or 29
232+both of the following ways: 30
233+1. At the nitrogen atom of the indole ring by an alkyl, haloalkyl, 31
234+cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 32
235+1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 33
236+1-(N-methyl-2-pyrrolidinyl)methyl, 34
237+1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 35
238+benzyl, or halo benzyl group; or 36
239+2. At the nitrogen of the acetamide by a phenyl, benzyl, naphthyl, 37
240+adamantyl, cyclopropyl, or propionaldehyde group; 38
241+whether or not the compound is further modified to any extent 39
242+in the following ways: (i) substitution to the indole ring to any 40
243+extent, (ii) substitution to the phenyl, benzyl, naphthyl, 41
244+adamantyl, cyclopropyl, or propionaldehyde group to any 42
245+extent, (iii) a nitrogen heterocyclic analog of the indole ring, or 43
246+(iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 44
247+naphthyl, adamantyl, or cyclopropyl ring. Substances in this 45
248+class include, but are not limited to: AFUBIATA, CH-PIATA, 46
249+AB-CHMIATA, ADB-FUBIATA. 47
250+u. Indazole acetaldehydes. Any compound structurally derived from 48
251+1H-indazol-3-ylacetaldehyde or 1H -indazol-2-ylacetaldehyde 49
252+substituted in one or both of the following ways: 50 General Assembly Of North Carolina Session 2025
253+Page 6 House Bill 330-First Edition
254+1. At the nitrogen atom of the indazole ring by an alkyl, haloalkyl, 1
255+cyanoalkyl, alkenyl, cycloalkylmethyl, cycloalkylethyl, 2
256+1-(N-methyl-2-piperidinyl)methyl, 2-(4-morpholinyl)ethyl, 3
257+1-(N-methyl-2-pyrrolidinyl)methyl, 4
258+1-(N-methyl-3-morpholinyl)methyl, tetrahydropyranylmethyl, 5
259+benzyl, or halo benzyl group; or 6
260+2. At the nitrogen of the carboxamide by a phenyl, benzyl, 7
261+naphthyl, adamantyl, cyclopropyl, or propionaldehyde group; 8
262+whether or not the compound is further modified to any extent 9
263+in the following ways: (i) substitution to the indazole ring to 10
264+any extent, (ii) substitution to the phenyl, benzyl, naphthyl, 11
265+adamantyl, cyclopropyl, or propionaldehyde group to any 12
266+extent, (iii) a nitrogen heterocyclic analog of the indazole ring, 13
267+or (iv) a nitrogen heterocyclic analog of the phenyl, benzyl, 14
268+naphthyl, adamantyl, or cyclopropyl ring. Substances in this 15
269+class include, but are not limited to: ADB-BUTINAATA, 16
270+ADB-FUBINAATA. 17
271+v. Pyrazoles. Any compound structurally derived from 1H-pyrazole 18
272+substituted in all of the following ways: 19
273+1. At the 1 position of the pyrazole ring by an alkyl, haloalkyl, or 20
274+alkenyl group. 21
275+2. At the 3 position of the pyrazole ring by a halo benzyl or 22
276+propionaldehyde group. 23
277+3. At the 5 position of the pyrazole ring by a halo benzyl or 24
278+propionaldehyde group; 25
279+whether or not the compound is further modified by a 26
280+substitution to the propionaldehyde group to any extent. 27
281+Substances in this class include, but are not limited to: 28
282+3,5-ADB-4en-PFUPPYCA, 5-fluoro-3,5-AB-PFUPPYCA." 29
283+SECTION 1.(h) G.S. 90-90(2)h1. reads as rewritten: 30
284+"h1. Fentanyl immediate precursor chemical, 31
285+4-anilino-N-phenethyl-4-piperidine 32
286+(ANPP).4-anilino-N-phenethylpiperdine (ANPP)." 33
287+SECTION 1.(i) G.S. 90-91(k)11. reads as rewritten: 34
288+"11. Dehydrochlormethyltestosterone,Dehydrochloromethyltestosterone," 35
289+SECTION 1.(j) G.S. 90-91(k)16. reads as rewritten: 36
290+"16. Mesterolene,Mesterolone," 37
291+SECTION 2. This act is effective when it becomes law. 38